CFB
MIRM icon

Cullen/Frost Bankers’s Mirum Pharmaceuticals MIRM Stock Holding History

Cullen/Frost Bankers’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.86K Sell
33
-377
-92% -$37.9K ﹤0.01% 1241
2026
Q1 		$37.9K Buy
410
+27
+7% +$2.54K ﹤0.01% 858
2025
Q4 		$30.3K Buy
+383
New +$27.5K ﹤0.01% 905

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cullen/Frost Bankers's MIRM Position: Q2 2026 in Review

Cullen/Frost Bankers reduced its Mirum Pharmaceuticals (MIRM) stake by 92% in Q2 2026, selling an estimated $37.9K and leaving 33 shares worth $3.86K. The position accounts for ﹤0.01% of the portfolio, ranked #1241.

Cullen/Frost Bankers first reported a position in MIRM in Q4 2025 and has held it in 3 quarters since. The position peaked at $37.9K in Q1 2026. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Cullen/Frost Bankers held 33 shares of Mirum Pharmaceuticals worth $3.86K as of Q2 2026.
  • Cullen/Frost Bankers sold 377 Mirum Pharmaceuticals shares in Q2 2026, an estimated $37.9K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #1241 holding.
  • Cullen/Frost Bankers first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Cullen/Frost Bankers's Mirum Pharmaceuticals position peaked at $37.9K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.